O acetaldeído é um comprovado agente mutagênico e carcinogênico, pode ser produzido endogenamente pela oxidação do álcool ingerido em bebidas alcoólicas e alimentos ou exogenamente, inalado como poluente, advindo da oxidação de combustíveis fósseis e etanol. O efeito do acetaldeído foi avaliado em modelos celulares e animais com o propósito de avaliarmos o aumento do estresse oxidativo, por lipoperoxidação, fragmentação do DNA, e a formação de adutos DNA, tais como 8-oxo-7,8-dihidro-2-desoxiguanosina, além de, 1,N2-eteno-2-desoxiguanosina e 1,N2-propano-2-desoxiguanosina que foram analisados por HPLC acoplado a espectrometria de massa com a utilização de metodologia ultra-sensível e reprodutiva. O tratamento de fibroblastos pulmonares humanos normais (IMR-90) com diversas concentrações de acetaldeído (58 µM a 711 µM) resultou em aumentos de morte celular, lipoperoxidação, fragmentação do DNA, cálcio intracelular e adutos de DNA. O efeito protetor do licopeno (20 µM) foi comprovado minimizando todos os efeitos deletérios promovidos pelo acetaldeído. O tratamento dos ratos Wistar por 8 e 30 dias com 150 mg/kg e 60 mg/kg via intra-peritoneal ou gavage, evidenciaram os efeitos tóxicos provocados pelo acetaldeído, como aumento significativo de lipoperoxidação, adutos e fragmentação de DNA no fígado e cérebro destes animais. A detecção dos adutos de DNA se mostrou uma ferramenta importante para a detecção dos efeitos provocados por exposição ao aldeído. No tratamento de animais por inalação com variadas concentrações de acetaldeído, que expôs os animais a quantidades do aldeído similares às encontradas em atmosferas poluídas, foi observado aumento de lipoperoxidação, sendo este dose dependente no fígado e pulmão. Já no cérebro, os níveis de MDA foram significativamente maiores em 10 ppb e 30 ppb em relação a 0 ppb e controle, e diminuíram significativamente em 90 ppb. Em relação aos níveis de fragmentação do DNA, observamos no pulmão aumento foi dose dependente em relação à concentração de aldeído. A quantificação de 1,N2-εdGuo e 1,N2-propanodGuo mostrou aumentos de ambos os adutos no pulmão de todos animais expostos ao acetaldeído . No fígado, também, foram detectados aumentos nos níveis de 1,N2-propanodGuo. A formação de 8-oxo-7,8-dihidro-2-desoxiguanosina, 1,N2-eteno-2-desoxiguanosina e 1,N2-propano-2-desoxiguanosina na urina de moradores da cidade de São Paulo, também foi investigada, com o desenvolvimento de metodologia ultra-sensível e reprodutiva por HPLC e espectrometria de massa, que indicou a presença dos três adutos nas urinas analisadas. A detecção do 1,N2-propanodGuo na urina é inédita. Nossos resultados comprovam que o acetaldeído é um forte agente citotóxico e genotóxico, mesmo em concentrações muito baixas, podendo contribuir para o esclarecimento dos mecanismos de desenvolvimento de doenças atribuídas ao aldeído, como o câncer. Além disso, o desenvolvimento de metodologias ultra-sensíveis para detecção e quantificação de adutos na urina e DNA isolado contribui para o emprego destes adutos, em especial o 1,N2-propano- 2-desoxiguanosina, como possível biomarcador de exposição ao acetaldeído presente em atmosferas poluídas e em patologias associadas ao estresse redox e abuso de bebidas alcoólicas. / Acetaldehyde is a known mutagen and carcinogen that can be produced endogenously by ethanol oxidation or directly inhaled as an air pollutant produced by fuel oxidation. The toxicity of acetaldehyde was evaluated in vitro and in vivo models, by means of oxidative stress parameters such as lipid peroxidation (measured as malonaldialdehyde -MDA), DNA fragmentation and DNA adducts such as 8-oxo-7,8-dihydro-2-desoxiguanosine, 1,N2-eteno-2-desoxiguanosine and 1,N2-propano-2-desoxiguanosine, this adducts were analyzed by an ultra-sensible and reproducible HPLC coupled to mass spectrometry assay. Treatment of human normal fibroblast (IMR-90) with a wide range of concentrations (58 µM to 711 µM) resulted in an increase in citotoxicity, lipid peroxidation, DNA fragmentation, intracellular calcium release and DNA adducts. Furthermore, lycopene (20 µM) presented a protective effect against the cellular deleterious properties of acetaldehyde. Treatment of Wistar rats for 8 and 30 days with 150 mg/kg and 60 mg/kg intra-peritonially or by gavage resulted in increased toxicity, measured by lipid peroxidation and DNA damage in liver and brain. The detection of DNA adducts was shown an important tool for the identification of deleterious effects induced by exposure to the aldehyde. Animals treated by inhalation, of amounts commonly found in polluted air samples, presented increased levels of lipid peroxidation in a dose dependent manner in liver and lungs. Nevertheless, in the brain of those animals the higher concentration was devoid of toxic effect measured as MDA levels. Lung tissue presented increased levels of DNA fragmentation. Furthermore, increased levels of 1,N2-εdGuo and 1,N2-propanodGuo was also observed in lungs of all animals. In DNA from livers, 1,N2-propanodGuo presented increased levels. Formation of 8-oxo-7,8-dihydro-2-desoxiguanosine, 1,N2-eteno-2-desoxiguanosine and 1,N2-propano-2-desoxiguanosine in urine samples of people living in the city of São Paulo were also investigated using a newly developed and ultra-sensible methodology base in HPLC coupled to mass spectrometry. This methodology enabled us to detect, for the first time, the presence of 1,N2-propanodGuo in urine samples. In summary, our results demonstrate the acetaldehyde is a strong cytotoxic and genotoxic agent even at low concentrations, being able to contribute to the development of pathology such as cancer. Furthermore, the development of a very ultra-sensitive methodology for the detection of these adducts, mainly ,N2-propano- 2-desoxiguanosine, enables its use as a possible biomarker of acetaldehyde exposure in polluted air samples and in pathologies associated with redox unbalance and ethanol consumption.

O acetaldeído é um comprovado agente mutagênico e carcinogênico, pode ser produzido endogenamente pela oxidação do álcool ingerido em bebidas alcoólicas e alimentos ou exogenamente, inalado como poluente, advindo da oxidação de combustíveis fósseis e etanol. O efeito do acetaldeído foi avaliado em modelos celulares e animais com o propósito de avaliarmos o aumento do estresse oxidativo, por lipoperoxidação, fragmentação do DNA, e a formação de adutos DNA, tais como 8-oxo-7,8-dihidro-2-desoxiguanosina, além de, 1,N2-eteno-2-desoxiguanosina e 1,N2-propano-2-desoxiguanosina que foram analisados por HPLC acoplado a espectrometria de massa com a utilização de metodologia ultra-sensível e reprodutiva. O tratamento de fibroblastos pulmonares humanos normais (IMR-90) com diversas concentrações de acetaldeído (58 µM a 711 µM) resultou em aumentos de morte celular, lipoperoxidação, fragmentação do DNA, cálcio intracelular e adutos de DNA. O efeito protetor do licopeno (20 µM) foi comprovado minimizando todos os efeitos deletérios promovidos pelo acetaldeído. O tratamento dos ratos Wistar por 8 e 30 dias com 150 mg/kg e 60 mg/kg via intra-peritoneal ou gavage, evidenciaram os efeitos tóxicos provocados pelo acetaldeído, como aumento significativo de lipoperoxidação, adutos e fragmentação de DNA no fígado e cérebro destes animais. A detecção dos adutos de DNA se mostrou uma ferramenta importante para a detecção dos efeitos provocados por exposição ao aldeído. No tratamento de animais por inalação com variadas concentrações de acetaldeído, que expôs os animais a quantidades do aldeído similares às encontradas em atmosferas poluídas, foi observado aumento de lipoperoxidação, sendo este dose dependente no fígado e pulmão. Já no cérebro, os níveis de MDA foram significativamente maiores em 10 ppb e 30 ppb em relação a 0 ppb e controle, e diminuíram significativamente em 90 ppb. Em relação aos níveis de fragmentação do DNA, observamos no pulmão aumento foi dose dependente em relação à concentração de aldeído. A quantificação de 1,N2-εdGuo e 1,N2-propanodGuo mostrou aumentos de ambos os adutos no pulmão de todos animais expostos ao acetaldeído . No fígado, também, foram detectados aumentos nos níveis de 1,N2-propanodGuo. A formação de 8-oxo-7,8-dihidro-2-desoxiguanosina, 1,N2-eteno-2-desoxiguanosina e 1,N2-propano-2-desoxiguanosina na urina de moradores da cidade de São Paulo, também foi investigada, com o desenvolvimento de metodologia ultra-sensível e reprodutiva por HPLC e espectrometria de massa, que indicou a presença dos três adutos nas urinas analisadas. A detecção do 1,N2-propanodGuo na urina é inédita. Nossos resultados comprovam que o acetaldeído é um forte agente citotóxico e genotóxico, mesmo em concentrações muito baixas, podendo contribuir para o esclarecimento dos mecanismos de desenvolvimento de doenças atribuídas ao aldeído, como o câncer. Além disso, o desenvolvimento de metodologias ultra-sensíveis para detecção e quantificação de adutos na urina e DNA isolado contribui para o emprego destes adutos, em especial o 1,N2-propano- 2-desoxiguanosina, como possível biomarcador de exposição ao acetaldeído presente em atmosferas poluídas e em patologias associadas ao estresse redox e abuso de bebidas alcoólicas. / Acetaldehyde is a known mutagen and carcinogen that can be produced endogenously by ethanol oxidation or directly inhaled as an air pollutant produced by fuel oxidation. The toxicity of acetaldehyde was evaluated in vitro and in vivo models, by means of oxidative stress parameters such as lipid peroxidation (measured as malonaldialdehyde -MDA), DNA fragmentation and DNA adducts such as 8-oxo-7,8-dihydro-2-desoxiguanosine, 1,N2-eteno-2-desoxiguanosine and 1,N2-propano-2-desoxiguanosine, this adducts were analyzed by an ultra-sensible and reproducible HPLC coupled to mass spectrometry assay. Treatment of human normal fibroblast (IMR-90) with a wide range of concentrations (58 µM to 711 µM) resulted in an increase in citotoxicity, lipid peroxidation, DNA fragmentation, intracellular calcium release and DNA adducts. Furthermore, lycopene (20 µM) presented a protective effect against the cellular deleterious properties of acetaldehyde. Treatment of Wistar rats for 8 and 30 days with 150 mg/kg and 60 mg/kg intra-peritonially or by gavage resulted in increased toxicity, measured by lipid peroxidation and DNA damage in liver and brain. The detection of DNA adducts was shown an important tool for the identification of deleterious effects induced by exposure to the aldehyde. Animals treated by inhalation, of amounts commonly found in polluted air samples, presented increased levels of lipid peroxidation in a dose dependent manner in liver and lungs. Nevertheless, in the brain of those animals the higher concentration was devoid of toxic effect measured as MDA levels. Lung tissue presented increased levels of DNA fragmentation. Furthermore, increased levels of 1,N2-εdGuo and 1,N2-propanodGuo was also observed in lungs of all animals. In DNA from livers, 1,N2-propanodGuo presented increased levels. Formation of 8-oxo-7,8-dihydro-2-desoxiguanosine, 1,N2-eteno-2-desoxiguanosine and 1,N2-propano-2-desoxiguanosine in urine samples of people living in the city of São Paulo were also investigated using a newly developed and ultra-sensible methodology base in HPLC coupled to mass spectrometry. This methodology enabled us to detect, for the first time, the presence of 1,N2-propanodGuo in urine samples. In summary, our results demonstrate the acetaldehyde is a strong cytotoxic and genotoxic agent even at low concentrations, being able to contribute to the development of pathology such as cancer. Furthermore, the development of a very ultra-sensitive methodology for the detection of these adducts, mainly ,N2-propano- 2-desoxiguanosine, enables its use as a possible biomarker of acetaldehyde exposure in polluted air samples and in pathologies associated with redox unbalance and ethanol consumption.

Ultraviolet radiation (UVR) is known to be highly mutagenic. What types of DNA lesions that are induced by different UVR wavelengths are still a matter of debate. UVR induces mutagenesis mostly by the formation of photoproducts and the induction of reactive oxygen species (ROS). ROS can give rise to mutations via oxidation of nucleotides in the DNA or the nucleotide pool. Oxidized nucleotides in the nucleotide pool can thereby be incorporated into the DNA during replication and ultimately give rise to mutations. MTH1 however, dephosphorylates oxidized nucleotides in the nucleotide pool, in particular 8-oxo-dGTP and 2-OH-dATP, and inhibits their incorporation into the DNA.The aim of the present study was to investigate the role of MTH1 in mutagenesis and cytogenetic damage induced by UVR in a human lymphoblastoid TK6 cell line. The clonogenic survival, mutant frequency and micronucleus frequency were measured following exposure to UVA, UVB and UVC in MTH1-knockdown and wild-type TK6 cells. As a biomarker for oxidative damage the level of intracellular and extracellular 8-oxo-dG was measured in TK6 cells exposed to UVA. The mutational spectra of UVA-induced mutations at the thymidine kinase gene in MTH1-knockdown and wild-type TK6 cells were investigated.The results show that MTH1 protects against UVA and UVB mutagenesis significantly. MTH1, however, has been shown to offer no protection against UVR-induced cytogenetic damage and is therefore suggested to mainly inhibit mutagenesis. The mutational spectra show that GC&gt;AT and AT&gt;GC transitions are the dominant mutation types in cells exposed to UVA.In conclusion, MTH1 protects TK6 cells against mutagenesis induced by longer wavelengths of UVR. This indicates that the nucleotide pool is a significant target in mutagenesis for longer wavelengths of UVR. The type of mutations induced by UVA, GC&gt;AT and AT&gt;GC, can be formed by the incorporation of 2-OH-dATP from nucleotide pool into the DNA. UVA is therefore suggested to induce mutations by induction of oxidized nucleotides such as 2-OH-dATP. / <p>At the time of the doctoral defense, the following paper was unpublished and had a status as follows: Paper 4: Manuscript.</p>

8-oxo-7,8-dihydroguanine (8oxoG) is one of the most important base lesions formed during oxidative damage of DNA. The aim of the present research was to investigate the effects of DNA concentration, G content, and the nature of oxidizing species on the kinetics of 8oxoG in model DNA solutions by using HPLC. The experimentally obtained yields of 8oxoG were typically in the range of 2-2.5% of total concentration of guanine. The ratios of the rate constant of hole diffusion in DNA to the rate constant of conversion of the hole into 8oxoG (kd/kr) were calculated from the experimental data using the diffusion model of charge transfer in DNA to be in the range of 200-300, in agreement with previously reported kd/kr ratios in the duplex DNA oligonucleotides (GGA)n or (GGTT)n. Our current diffusion model cannot satisfactorily explain the absence of the G content dependence of the 8oxoG yields, which indicates that a more advanced model is required.

<p>Radiotherapy is one of the most common therapeutic methods for treatment of many types of cancer. Despite many decades of development and experience there is much to improve, both in efficacy of treatment and to decrease the incidences of adverse healthy tissue reactions. Around 20 % of the radiotherapy patients show a broad range in the severity of normal tissue reactions to radiotherapy, and dose limits are governed by severe reactions in the most radiosensitive patients (< 5 %). Identification of patients with low, moderate or high clinical radiosensitivity before commencing of radiotherapy would allow individual adaptation of the maximum dose with an overall increase in the cure rate. Characterization of factors that may modify the biological effects of ionizing radiation has been a subject of intense research efforts. Still, there is no assay currently available that can reliably predict the clinical radiosensitivity. The aim of this work has been to investigate the role of oxidative stress in individual radiosensitivity and evaluate novel markers of radiation response, which could be adapted for clinical use.</p><p>8-Oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a general marker of oxidative stress, is one of the major products of interaction of ionizing radiation with DNA and the nucleotide pool of the cell. As 8-oxo-dG is highly mutagenic due to incorrect base pairing with deoxyadenosine, various repair mechanisms recognize and remove 8-oxo-dG. The repaired lesions are released from cells to the extracellular milieu (serum, urine and cell culture medium) where they can be detected as markers for free radical reactions with the nucleic acids.</p><p>Significant variations in background levels as well as in radiation induced levels of 8-oxo-dG in urine have been demonstrated in breast cancer patients (paper 1). Two major patterns were observed: high background and no therapy-related increase vs. low background and significant increase during radiotherapy for the radiosensitive and non radiosensitive patients respectively.</p><p>Studies in paper 2 indicated major contribution of the nucleotide pool to the extracellular 8-oxo-dG levels. The results also implicated induction of prolonged endogenous oxidative stress in the irradiated cells. RNA “knock-down” experiments on the nucleotide pool sanitization enzyme hMTH1 in paper 3 lend further experimental evidence to this assumption.</p><p>The applicability of 8-oxo-dG as a diagnostic marker of oxidative stress was demonstrated in paper 4. Studies on dialysis patients revealed a good correlation between inflammatory responses (known to be associated with persistent oxidative stress) and extracellular 8-oxo-dG.</p><p>In summary, our results confirm that extracellular 8-oxo-dG is a sensitive <i>in vivo</i> biomarker of oxidative stress, primarily formed by oxidative damage of dGTP in the nucleotide pool with a potential to become a clinical tool for prediction of individual responses to radiotherapy.</p>

Radiotherapy is one of the most common therapeutic methods for treatment of many types of cancer. Despite many decades of development and experience there is much to improve, both in efficacy of treatment and to decrease the incidences of adverse healthy tissue reactions. Around 20 % of the radiotherapy patients show a broad range in the severity of normal tissue reactions to radiotherapy, and dose limits are governed by severe reactions in the most radiosensitive patients (&lt; 5 %). Identification of patients with low, moderate or high clinical radiosensitivity before commencing of radiotherapy would allow individual adaptation of the maximum dose with an overall increase in the cure rate. Characterization of factors that may modify the biological effects of ionizing radiation has been a subject of intense research efforts. Still, there is no assay currently available that can reliably predict the clinical radiosensitivity. The aim of this work has been to investigate the role of oxidative stress in individual radiosensitivity and evaluate novel markers of radiation response, which could be adapted for clinical use. 8-Oxo-7,8-dihydro-2'-deoxyguanosine (8-oxo-dG), a general marker of oxidative stress, is one of the major products of interaction of ionizing radiation with DNA and the nucleotide pool of the cell. As 8-oxo-dG is highly mutagenic due to incorrect base pairing with deoxyadenosine, various repair mechanisms recognize and remove 8-oxo-dG. The repaired lesions are released from cells to the extracellular milieu (serum, urine and cell culture medium) where they can be detected as markers for free radical reactions with the nucleic acids. Significant variations in background levels as well as in radiation induced levels of 8-oxo-dG in urine have been demonstrated in breast cancer patients (paper 1). Two major patterns were observed: high background and no therapy-related increase vs. low background and significant increase during radiotherapy for the radiosensitive and non radiosensitive patients respectively. Studies in paper 2 indicated major contribution of the nucleotide pool to the extracellular 8-oxo-dG levels. The results also implicated induction of prolonged endogenous oxidative stress in the irradiated cells. RNA “knock-down” experiments on the nucleotide pool sanitization enzyme hMTH1 in paper 3 lend further experimental evidence to this assumption. The applicability of 8-oxo-dG as a diagnostic marker of oxidative stress was demonstrated in paper 4. Studies on dialysis patients revealed a good correlation between inflammatory responses (known to be associated with persistent oxidative stress) and extracellular 8-oxo-dG. In summary, our results confirm that extracellular 8-oxo-dG is a sensitive in vivo biomarker of oxidative stress, primarily formed by oxidative damage of dGTP in the nucleotide pool with a potential to become a clinical tool for prediction of individual responses to radiotherapy.

Le gène RhDIF1 s'exprime uniquement dans les pétales de roses parfumées et au moment où la fleur produit des monoterpènes comme le géraniol, le citronellol ou le nérol. RhDIF1est donc un gène candidat pour être impliqué dans la production de monoterpènes chez les roses parfumées. Le travail de cette thèse consiste à trouver une explication pour l'absence de l'expression de RhDIFI1 chez des roses peu parfumées et à caractériser moléculairement la protéine recombinante RhDIF1. L'absence d'expression de RhDIF1 chez les roses peu parfumées est probablement due à des perturbations importantes dans le promoteur du gène en comparaison avec le promoteur de RhDIF1 chez une rose parfumée. La séquence de la protéine RhDIF1 possède un domaine caractéristique nudix hydrolase. Les nudix hydrolases sont des pyrophosphohydrolases clivant par exemple des dNTPs oxydés mutagènes, des molécules tels que l'ADP-ribose potentiellement toxiques ou encore le NADP. Des essais d'activités enzymatiques de la protéine RhDIF1 avec du GPP n'ont pas montré la production de monoterpènes. Une potentielle activité IPP isomérase de RhDIF1 doit être testée. Aussi, des conversions entre le géraniol et d'autres monoterpènes chez les roses parfumées peuvent nécessiter du NADP comme cofacteur et une possible implication de RhDIF1 dans ces réactions via le métabolisme du NADP doit également être vérifiée. Sur la base de l’homologie de séquence de RhDIF1 avec la 8-oxo-dGTPase AtNUDX1 d’Arabidopsis thaliana, des essais d'activités enzymatiques avec le dATP, dCTP, dGTP, dTTP et le nucléotide oxydé mutagène 8-oxo-dGTP ont montré que RhDIF1 clive ces substrats sauf le dCTP. En outre, la détermination de valeurs de Km vis à vis de ces dNTPs tendent à montrer que RhDIF1 clive préférentiellement des substrats contenant une purine. Une activité spécifique de RhDIF1 sur le dATP nettement supérieure à celles des autres dNTPs nous incitent à nous poser la question si le nucléotide oxydé mutagène 2-hydroxy-dATP n'est pas aussi un potentiel substrat de RhDIF1. Dans l'hypothèse où RhDIF1 serait une nudix hydrolase dégradant des dNTPs oxydés mutagènes, RhDIF1 aurait alors comme rôle la détoxification du pool de nucléotide en éliminant les dNTPs oxydés apparus suite à un stress oxydatif pouvant avoir comme origine la production de géraniol par les pétales de rose / The expression of the RhDIF1 gene is observed only in petals of scented roses when the flower emit monoterpenes. Thus, RhDIF1 has been thought to be involved in the production of such compouds in scented roses. During this thesis, an explanation for the absence of expression of RhDIF1 in non-scented roses and a molecular characterization of the RhDIF1 recombinant protein have been investigated. The absence of expression of RhDIF1 in non-scented roses may be due to strong modifications observed in the promoter compared to the RhDIF1 homolog in a scented rose. A typical nudix domain is included in the RhDIF1 protein sequence. Nudix hydrolases are pyrophosphohydrolases cleaving mutagenic oxidated dNTPs, potentially toxic molecules like ADP-ribose or NADP for examples. Enzymatic assays of RhDIF1 with GPP showed any production of monoterpenes. A potential IPP isomerase activity of RhDIF1 must be tested. Also, conversions between geraniol and other monoterpenes in scented roses may needs NADP as cofactor and a possible involvement of RhDIF1 in these reactions via the NADP metabolism must be checked too. Based on the sequence homology between RhDIFI1and the Arabidopsis thaliana 8-oxo-dGTPase AtNUDX1, enzymatic assays with RhDIF1 and dATP, dCTP, dGTP, dTTP and the mutagenic oxidated nucleotide 8-oxo-dGTP showed a catalytic activity of RhDIF1 on these substracts excepted for dCTP. Moreover, Km values seem to show that RhDIF1 preferentially cleaves purine containing substract. A specific activity higher for dATP than the other dNTP lead us to think if the mutagenic oxidated nucleotide 2-hydroxy-dATP could be a potential substract for RhDIF1. Thus, RhDIF1 could be involved in the nucleotide pool sanitization by eliminating oxidated nucleotides appeared from an oxidative stress potentially due to the geraniol production by rose petal

No description available.

Les oxydations sur les bases nucléiques constituent l’une des sources principale d’apparition de lésions sur l’ADN, qui peuvent être mutagènes ou létales pour les cellules en l’absence de réparation de l’ADN. La Formamidopyrimidine-ADN glycosylase (Fpg), une enzyme procaryote du système de réparation de l’ADN par excision de base (BER), initie la réparation d’un large panel de lésions de ce type via ses activités ADN glycosylase (excision de la base oxydée) et AP lyase (clivage du site abasique par ß,d-élimination). Nous avons réalisé des études fonctionnelles par des techniques biochimiques et structurales par cristallographie des rayons X afin de préciser la spécificité de substrat et le mécanisme catalytique de Fpg. Ainsi, nous avons pu mettre en évidence des déterminants structuraux permettant à cette enzyme d’accommoder des lésions de tailles très différentes dans son site actif, en l’occurrence des résidus 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyG) substitués ou non en N7 par des adduits encombrants. D’autre part, nous avons caractérisé structuralement et fonctionnellement la reconnaissance et l’excision par Fpg d’une lésion pyrimidique, la 5-hydroxy-5-méthyle-hydantoïne (Hyd). Ainsi, nous avons montré que cette lésion appariée à une cytosine était un bon substrat pour l’enzyme, et nous avons précisé structuralement le mode de reconnaissance de l’Hyd par Fpg. D’autre part, nous avons mis en évidence un comportement inattendu de l’enzyme sur ce substrat. En l’occurrence, nous avons montré biochimiquement et structuralement qu’un pontage covalent se formait en quantités non négligeables entre Fpg et l’Hyd dans des conditions physiologiques. / Oxidations on nucleic bases constitute one of the major sources of DNA lesions appearance, which can be mutagenic or lethal for cells in the absence of DNA repair. The prokaryotic Formamidopyrimidine-DNA glycosylase (Fpg), a base excision DNA repair (BER) enzyme, initiate the repair of a wide range of such lesions via its DNA glycosylase (excision of the oxidized base) and AP lyase (cleavage of the AP site by ß,d-elimination) activities. We carried out functional studies by biochemical techniques and structural studies by X-ray crystallography so as to state Fpg’s substrate specificity and catalytic mechanism. Thus, we have been able to underline the structural determinants enabling this enzyme to accommodate lesions of very different sizes in its active site, in this case 2,6-diamino-4-hydroxy-5-formamidopyrimidine (FapyG) residues N7-substituted or not by bulky adducts. On the other hand, we structurally and functionally characterized the recognition and excision by Fpg of a pyrimidic lesion, the 5-hydroxy-5-methyl-hydantoin (Hyd). Thus, we have shown that this lesion paired with a cytosine was a good substrate for the enzyme, and stated structurally the recognition mode of Hyd by Fpg. On the other hand, we have underlined an unexpected behaviour of the enzyme on this substrate. In this case, we have biochemically and structurally shown that a covalent link was formed in sizeable quantities between Fpg and Hyd in physiological conditions.

Fifty percent of solid cancers are treated with radiation therapy (RT). The dose used in RT is adjusted to the most sensitive individuals so that not more than 5% of the patients will have severe adverse healthy tissue effects. As a consequence, the majority of the patients will receive a suboptimal dose, as they would have tolerated a higher total dose and received a better tumor control. Thus, if RT could be individualized based on radiation sensitivity (RS), more patients would be cured and the most severe adverse reactions could be avoided. At present the mechanisms behind RS are not known. The long term aim of this thesis was to develop diagnostic tools to assess the individual RS of breast cancer patients and to better understand the mechanisms behind the RS and radiation effects after low dose exposures. The approach was based on the hypothesis that biomarkers of individual RS, in terms of acute adverse skin reactions after breast cancer RT, can be found in whole blood that has been stressed by low doses of ionizing radiation (IR).  To reach this goal two different approaches to identify biomarkers of RS have been investigated. A protocol for the analysis of differential protein expression in response to low dose in vitro irradiated whole blood was developed (paper I). This protocol was then used to investigate the proteomic profile of radiation sensitive and normo-sensitive patients, using isotope-coded protein labeled proteomics (ICPL). The results from the ICPL study (paper III) show that the two patient groups have different protein expression profiles both at the basal level and after IR. In paper II the potential biomarker 8-oxo-dG was investigated in serum after IR. The relative levels of IR induced 8-oxo-dG from radiation sensitive patients differ significantly from normo-sensitive patients. This indicates that the sensitive patients differ in their cellular response to IR and that 8-oxo-dG is a potential biomarker for RS. / <p>At the time of the doctoral defense, the following paper was unpublished and had a status as follows: Paper 3: Manuscript.</p>